MedPath

JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

106

HSA:106

Drug Approvals

Clinical Trials

A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy

Completed
Conditions
High Risk Localized Prostate Cancer
First Posted Date
2022-03-31
Last Posted Date
2024-08-05
Lead Sponsor
Johnson & Johnson International (Singapore) Pte. Ltd.
Target Recruit Count
221
Registration Number
NCT05303558
Locations
🇯🇵

Akita University Hospital, Akita, Japan

🇯🇵

Hirosaki University Hospital, Hirosaki, Japan

🇯🇵

Nagoya City University Hospital, Nagoya-shi, Japan

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.